Clinical trials: Visual Sensitivity in Newborns, active

Retinitis Pigmentosa

Oral N-acetylcysteine for Retinitis Pigmentosa

• Active, not recruiting
• Age: 18 to 65 years
• Phase 3

Retinitis pigmentosa (RP) is an inherited retinal degeneration caused by one of several mistakes in the genetic code. Such mistakes are called mutations.

Trial name

NAC Attack (NCT05537220)

Testing

N-acetylcysteine

Where

31 sites in United States, Austria and 5 more

Volunteers

485 people

Sponsor

Johns Hopkins University